| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.078 | 0.06 |